Scholar Rock Holding Corp - 8-K Filing
Scholar Rock's FDA-approved SMA treatment ISEMBYLD shows statistically significant motor function improvement in Phase 3 trial (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $SRRK